Arecor Therapeutics PLC (AREC) — Financial Flexibility Index
Arecor Therapeutics PLC (AREC) has a Financial Flexibility Index of -0.70x as of December 2025. Free cash flow of GBX-1.15 Million (operating CF GBX-1.15 Million minus capex GBX1.00K) represents -1% of total liabilities (GBX1.65 Million). Check tangible net worth ratio of Arecor Therapeutics PLC to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Arecor Therapeutics PLC Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Arecor Therapeutics PLC across 9 annual periods. For the full cash flow conversion analysis, see Arecor Therapeutics PLC operating cash flow efficiency.
Annual Financial Flexibility Index for Arecor Therapeutics PLC (2018–2025)
Year-by-year free cash flow to debt coverage for Arecor Therapeutics PLC. Explore Arecor Therapeutics PLC (AREC) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.33x | GBX-2.19 Million | GBX-2.29 Million | GBX1.65 Million | ▲ +50.9% |
| 2024 | -2.71x | GBX-9.13 Million | GBX-9.15 Million | GBX3.37 Million | ▼ -178.4% |
| 2023 | -0.97x | GBX-5.69 Million | GBX-5.84 Million | GBX5.85 Million | ▲ +59.8% |
| 2022 | -2.42x | GBX-10.44 Million | GBX-10.78 Million | GBX4.31 Million | ▼ -6.7% |
| 2021 | -2.27x | GBX-5.38 Million | GBX-5.45 Million | GBX2.37 Million | ▼ -341.3% |
| 2020 | -0.51x | GBX-1.80 Million | GBX-1.86 Million | GBX3.51 Million | ▼ -32.3% |
| 2019 | -0.39x | GBX-426.50K | GBX-458.80K | GBX1.10 Million | ▲ +80.3% |
| 2019 | -1.97x | GBX-2.43 Million | GBX-2.50 Million | GBX1.23 Million | ▼ -473.2% |
| 2018 | -0.34x | GBX-479.65K | GBX-492.57K | GBX1.40 Million | — |